Last reviewed · How we verify

NCT04058691: FEOR

Prospective/Retrospective Registry of the E-vita OPEN PLUS Stent Graft System in France

Completed Last updated 25 January 2023
What this trial tests

trial testing Surgical repair in Vascular Diseases in 100 participants. Completed in 30 September 2022.

Timeline
1 November 2019
Primary endpoint
20 February 2020
30 September 2022

Quick facts

Lead sponsorJOTEC GmbH
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date1 November 2019
Primary completion20 February 2020
Estimated completion30 September 2022
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

JOTEC GmbH

Who can join

Eligibility, any sex, with Vascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The FEOR registry is undertaken to examine the real-world data of patients that were treated with the E-vita OPEN Plus Stent Graft System under routine care in France. This registry is a requirement of the Haute Autorité de Santé (HAS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Surgical repair

Trials testing the same drug.

Other recruiting trials for Vascular Diseases

Currently open trials in the same condition.

Other JOTEC GmbH trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04058691.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing